PHGE Rentabilitas dodolan reged BiomX Inc.

Simbol resmi perusahaan biomx.com (PHGE)

The gross margin chart demonstrates the efficiency of BiomX Inc. (PHGE) cold chain and diversified raw material supplies, with -691.90 serving as the base parameter value. The current share price already prices in R&D costs and asset integration while awaiting the results of phase two phage cocktail trials. Growth potential is based on strategic partnerships with institutions to create antibiotic alternatives.

PHGE Margin reged BiomX Inc (04.07.2022 - 11.09.2026)

Rincian analitis lan laporan data perusahaan biomx.com (PHGE)

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:PHGE, BiomX
Produk seri BiomX Inc.

Gross margin measures production efficiency, reflecting the portion of revenue remaining after covering direct costs to form the base for operating activities. An analysis of the business's gross margins allows for an assessment of the resilience of BiomX Inc., whose revenues from phage therapy are independent of economic cycles and are instead determined by the success of clinical trials and patent protection.